These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Plasma collagen cofactor correlates with von Willebrand factor antigen and ristocetin cofactor but not with bleeding time. Aihara M, Kimura A, Chiba Y, Yoshida Y. Thromb Haemost; 1988 Jun 16; 59(3):485-90. PubMed ID: 3142084 [Abstract] [Full Text] [Related]
3. Laboratory testing for von Willebrand's disease: an assessment of current diagnostic practice and efficacy by means of a multi-laboratory survey. RCPA Quality Assurance Program (QAP) in Haematology Haemostasis Scientific Advisory Panel. Favaloro EJ, Smith J, Petinos P, Hertzberg M, Koutts J. Thromb Haemost; 1999 Oct 16; 82(4):1276-82. PubMed ID: 10544913 [Abstract] [Full Text] [Related]
4. Von Willebrand's disease with spontaneous platelet aggregation induced by an abnormal plasma von Willebrand factor. Grainick HR, Williams SB, McKeown LP, Rick ME, Maisonneuve P, Jenneau C, Sultan Y. J Clin Invest; 1985 Oct 16; 76(4):1522-9. PubMed ID: 2932469 [Abstract] [Full Text] [Related]
5. Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content. Weiss HJ, Hoyer LW, Rickles FR, Varma A, Rogers J. J Clin Invest; 1973 Nov 16; 52(11):2708-16. PubMed ID: 4542944 [Abstract] [Full Text] [Related]
7. von Willebrand factor activity detected in a monoclonal antibody-based ELISA: an alternative to the ristocetin cofactor platelet agglutination assay for diagnostic use. Murdock PJ, Woodhams BJ, Matthews KB, Pasi KJ, Goodall AH. Thromb Haemost; 1997 Oct 16; 78(4):1272-7. PubMed ID: 9364997 [Abstract] [Full Text] [Related]
10. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio. Gadisseur A, Berneman Z, Schroyens W, Michiels JJ. Acta Haematol; 2009 Oct 16; 121(2-3):128-38. PubMed ID: 19506359 [Abstract] [Full Text] [Related]
11. Abnormal antigenic reactivity of factor VIII/von Willebrand factor subunit in variants of von Willebrand's disease. Girma JP, Pietu G, Lavergne JM, Meyer D, Larrieu MJ. J Lab Clin Med; 1982 Apr 16; 99(4):481-94. PubMed ID: 6174657 [Abstract] [Full Text] [Related]
12. Validation of the first commercial ELISA for type 2N von Willebrand's disease diagnosis. Veyradier A, Caron C, Ternisien C, Wolf M, Trossaert M, Fressinaud E, Goudemand J. Haemophilia; 2011 Nov 16; 17(6):944-51. PubMed ID: 21371195 [Abstract] [Full Text] [Related]
13. A new variant of von Willebrand's disease (type I Padua): doublet-organized plasma von Willebrand factor oligomers in the presence of all size multimers. Casonato A, Pontara E, Dannhäuser D, Bertomoro A, Sartori MT, Girolami A. Haematologia (Budap); 1994 Nov 16; 26(2):97-109. PubMed ID: 7890268 [Abstract] [Full Text] [Related]
14. Heterogeneous abnormalities in the multimeric structure, antigenic properties, and plasma-platelet content of factor VIII/von Willebrand factor in subtypes of classic (type I) and variant (type IIA) von Willebrand's disease. Weiss HJ, Pietu G, Rabinowitz R, Girma JP, Rogers J, Meyer D. J Lab Clin Med; 1983 Mar 16; 101(3):411-25. PubMed ID: 6186757 [Abstract] [Full Text] [Related]
18. Response of von Willebrand factor parameters to desmopressin in patients with type 1 and type 2 congenital von Willebrand disease: diagnostic and therapeutic implications. Michiels JJ, van de Velde A, van Vliet HH, van der Planken M, Schroyens W, Berneman Z. Semin Thromb Hemost; 2002 Apr 16; 28(2):111-32. PubMed ID: 11992235 [Abstract] [Full Text] [Related]
19. An immunoradiometric assay for factor VIII related antigen (VIIIRAg) using two monoclonal antibodies-comparison with polyclonal rabbit antibodies for use in von Willebrand's disease diagnosis. Sultan Y, Avner P, Maisonneuve P, Arnaud D, Jeanneau C. Thromb Haemost; 1984 Dec 29; 52(3):250-2. PubMed ID: 6442468 [Abstract] [Full Text] [Related]
20. Laboratory assessment as a critical component of the appropriate diagnosis and sub-classification of von Willebrand's disease. Favaloro EJ. Blood Rev; 1999 Dec 29; 13(4):185-204. PubMed ID: 10741895 [Abstract] [Full Text] [Related] Page: [Next] [New Search]